Tonix Pharmaceuticals Holding (TNXP) Enterprise Value (QoQ) (2012 - 2026)
Tonix Pharmaceuticals Holding (TNXP) Enterprise Value (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Tonix Pharmaceuticals Holding | 142.07 Mn | 142.07 Mn | 5.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.30% |
| Dec 31, 2025 | -112.74% |
| Sep 30, 2025 | 3.84% |
| Jun 30, 2025 | 22.94% |
| Mar 31, 2025 | -32.14% |
| Dec 31, 2024 | -253.06% |
| Sep 30, 2024 | -117,537.50% |
| Jun 30, 2024 | 99.66% |
| Mar 31, 2024 | 72.73% |
| Dec 31, 2023 | -273.86% |
| Sep 30, 2023 | 73.01% |
| Jun 30, 2023 | 64.41% |
| Mar 31, 2023 | 40.25% |
| Dec 31, 2022 | 13.94% |
| Sep 30, 2022 | 3.78% |
| Jun 30, 2022 | -3.59% |
| Mar 31, 2022 | 21.50% |
| Dec 31, 2021 | 2.22% |
| Sep 30, 2021 | -10.41% |
| Jun 30, 2021 | -0.92% |